 
RGA 03.001 Clinical Trial Information - Oncology 
1 
 
RESPONSIBLE DEPARTMENT: 
Office of Research & Grant Administration 
SUBJECT:  
Clinical Trial information - Oncology 
PAGES: 
1-2 
REPLACES POLICY (NUMBER/DATE): 
 
ORIGINAL EFFECTIVE 
DATE:  
3/11/2022   
REVISIONS EFFECTIVE: 
 
3/4/2024 
POLICY NUMBER:  
AAOR024 
 
SCOPE: 
Applies to Our Lady of the Lake Hospital, Inc. (“OLOLH”) and its wholly owned sponsored organizations (collectively 
referred to herein as “Entity”) that propose and adopt Facility wide policies. 
PURPOSE: 
To ensure the employees and medical staff are aware of how clinical trial information is provided to oncology patients. 
POLICY: 
This policy explains how clinical trial information is provided to cancer patients in order to increase their awareness 
about clinical trials offered within OLOLH. 
DEFINITIONS: 
N/A 
 
PROCEDURE: 
Cancer related clinical trial information is provided to patients via the following procedures, processes and 
materials: 
1. Franciscan Missionaries of Our Lady Health System website 
a. https://www.fmolhs.org/research-education/research-and-grant-administration-office/clinical-trials  
2. Print Materials 
3. Social Media 
4.  Physicians, Clinical Research Nurses/Coordinators 
a. To increase clinicians and support staff clinical trial awareness, education regarding current 
clinical trial opportunities are discussed at: 
i. Cancer Committee Meetings 
ii. Multi-Disciplinary Care Meetings 
iii. Tumor Conferences 
5. Patient Navigators and Social Workers 
6. Cancer Program Outreach 
a. Screening Events 
b. Community Health Fairs 
c. Cancer Support Groups – internal and external 
d. Patient Advocacy Groups   
 
 
 
 
OUR LADY OF THE LAKE HOSPITAL 
 
RGA 03.001 Clinical Trial Information - Oncology 
2 
Note:  The information described herein does not create any legal rights and FMOLHS reserves the right to deviate 
from, revise or eliminate this policy, at any time, in its sole discretion. 
STATUTORY/REGULATORY AUTHORITY: 
• N/A 
ATTACHMENTS:  
• Information Card – “Benefits of Participating in a Clinical Trial” 
 
Policy Oversight by:  Chief Operating Officer  
 
TITLE:  Clinical Trial Information – Oncology  
 